Search

everythinglearnresearchcommunity

for

Search:↓

Systemic lupus erythematosus is diagnosed earlier in males than females.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Stopping azathioprine improved hair loss and bone marrow issues.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Upadacitinib effectively treats severe alopecia areata and is safe.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Pharmacists play a crucial role in health literacy and patient care.

Better supportive care is needed to manage chemotherapy side effects.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Ongoing research and innovation are crucial for improving skin care and treatment.

Baricitinib is more effective than methotrexate for severe alopecia areata.